Free Trial
Your Portfolio Deserves Better! MarketBeat All Access for Just $149
Upgrade Now
Claim MarketBeat All Access Sale Promotion

Amrize (AMRZ) Financials

Amrize logo
$48.20 -1.44 (-2.90%)
Closing price 03:59 PM Eastern
Extended Trading
$48.46 +0.26 (+0.54%)
As of 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Amrize

Annual Income Statements for Amrize

This table shows Amrize's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 956 1,274 1,185
Consolidated Net Income / (Loss)		 955 1,273 1,182
Net Income / (Loss) Continuing Operations		 955 1,273 1,182
Total Pre-Tax Income 		1,303 1,628 1,497
Total Operating Income		 1,888 2,195 1,906
Total Gross Profit		 2,769 3,070 3,034
Total Revenue		 11,677 11,704 11,815
Operating Revenue		 11,677 11,704 11,815
Total Cost of Revenue		 8,908 8,634 8,781
Operating Cost of Revenue		 8,908 8,634 8,781
Total Operating Expenses		 881 875 1,128
Selling, General & Admin Expense		 898 944 1,128
Impairment Charge		 15 2.00 15
Other Special Charges / (Income)		 -32 -71 -15
Total Other Income / (Expense), net		 -585 -567 -409
Interest & Investment Income		 -549 -512 -413
Other Income / (Expense), net		 -36 -55 4.00
Income Tax Expense		 361 368 326
Other Gains / (Losses), net		 13 13 11
Net Income / (Loss) Attributable to Noncontrolling Interest		 -1.00 -1.00 -3.00
Basic Earnings per Share		 $1.73 $2.30 $2.14
Weighted Average Basic Shares Outstanding		 553.10M 553.10M 553.10M
Diluted Earnings per Share		 $1.73 $2.30 $2.14
Weighted Average Diluted Shares Outstanding		 553.10M 553.10M 553.60M
Weighted Average Basic & Diluted Shares Outstanding		 - - 553.08M

Quarterly Income Statements for Amrize

This table shows Amrize's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 474 553 -87 429 545 -116
Consolidated Net Income / (Loss)		 473 552 -87 428 543 -118
Net Income / (Loss) Continuing Operations		 473 552 -87 428 543 -118
Total Pre-Tax Income 		620 703 -133 549 689 -145
Total Operating Income		 754 844 -16 669 778 -76
Total Gross Profit		 979 1,042 222 966 1,086 211
Total Revenue		 3,243 3,446 2,081 3,220 3,675 2,178
Operating Revenue		 3,243 3,446 2,081 3,220 3,675 2,178
Total Cost of Revenue		 2,264 2,404 1,859 2,254 2,589 1,967
Operating Cost of Revenue		 2,264 2,404 1,859 2,254 2,589 1,967
Total Operating Expenses		 225 198 238 297 308 287
Selling, General & Admin Expense		 228 241 239 299 312 292
Other Special Charges / (Income)		 -5.00 -43 -1.00 -4.00 -4.00 -5.00
Total Other Income / (Expense), net		 -134 -141 -117 -120 -89 -69
Interest & Investment Income		 -134 -130 -118 -121 -89 -70
Other Income / (Expense), net		 0.00 -11 1.00 1.00 0.00 1.00
Income Tax Expense		 149 155 -46 122 150 -27
Net Income / (Loss) Attributable to Noncontrolling Interest		 -1.00 -1.00 0.00 -1.00 -2.00 -2.00
Basic Earnings per Share		 $0.86 $1.00 ($0.16) $0.78 $0.99 ($0.21)
Weighted Average Basic Shares Outstanding		 553.10M 553.10M 553.10M 553.10M 553.10M 553.20M
Diluted Earnings per Share		 $0.86 $1.00 ($0.16) $0.78 $0.98 ($0.21)
Weighted Average Diluted Shares Outstanding		 553.10M 553.10M 553.10M 553.10M 553.90M 553.20M
Weighted Average Basic & Diluted Shares Outstanding		 - - - 553.08M 553.08M 553.54M

Annual Cash Flow Statements for Amrize

This table details how cash moves in and out of Amrize's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 756 478 337
Net Cash From Operating Activities		 2,036 2,282 2,208
Net Cash From Continuing Operating Activities		 2,036 2,282 2,208
Net Income / (Loss) Continuing Operations		 955 1,273 1,182
Consolidated Net Income / (Loss)		 955 1,273 1,182
Depreciation Expense		 851 889 914
Non-Cash Adjustments To Reconcile Net Income		 102 117 160
Changes in Operating Assets and Liabilities, net		 128 3.00 -48
Net Cash From Investing Activities		 -2,025 -1,208 -361
Net Cash From Continuing Investing Activities		 -2,025 -1,208 -361
Purchase of Property, Plant & Equipment		 -630 -642 -788
Acquisitions		 -1,607 -249 -86
Sale of Property, Plant & Equipment		 49 61 21
Other Investing Activities, net		 163 -378 492
Net Cash From Financing Activities		 734 -537 -1,555
Net Cash From Continuing Financing Activities		 734 -537 -1,555
Repayment of Debt		 -656 -381 -5,697
Issuance of Debt		 1,465 230 3,417
Other Financing Activities, net		 -75 -386 725
Effect of Exchange Rate Changes		 11 -59 45

Quarterly Cash Flow Statements for Amrize

This table details how cash moves in and out of Amrize's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2024 Q4 2024 Q1 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 60 1,165 -1,011 225 1,096 -823
Net Cash From Operating Activities		 623 1,727 -856 854 1,804 -896
Net Cash From Continuing Operating Activities		 623 1,727 -856 854 1,804 -896
Net Income / (Loss) Continuing Operations		 552 292 -87 543 298 -118
Consolidated Net Income / (Loss)		 552 292 -87 543 298 -118
Depreciation Expense		 228 225 218 231 244 236
Non-Cash Adjustments To Reconcile Net Income		 36 55 30 20 78 33
Changes in Operating Assets and Liabilities, net		 -193 1,155 -1,017 60 1,184 -1,047
Net Cash From Investing Activities		 -425 -352 -60 -202 -150 -659
Net Cash From Continuing Investing Activities		 -425 -352 -60 -202 -150 -659
Purchase of Property, Plant & Equipment		 -221 -84 -211 -185 -157 -272
Acquisitions		 -21 -228 -9.00 -8.00 - -425
Sale of Property, Plant & Equipment		 19 28 2.00 5.00 9.00 5.00
Other Investing Activities, net		 -202 -68 158 -14 -2.00 33
Net Cash From Financing Activities		 -143 -163 -97 -419 -577 743
Net Cash From Continuing Financing Activities		 -143 -163 -97 -419 -577 743
Repayment of Debt		 -49 -343 -8.00 -6.00 1.00 0.00
Issuance of Debt		 20 210 22 -386 -547 777
Other Financing Activities, net		 -114 -30 -111 -27 -31 -34
Effect of Exchange Rate Changes		 5.00 -47 2.00 -8.00 19 -11

Annual Balance Sheets for Amrize

This table presents Amrize's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2025
Period end date 12/31/2024 12/31/2025
Total Assets		 23,805 24,249
Total Current Assets		 4,781 4,681
Cash & Equivalents		 1,585 1,922
Accounts Receivable		 1,069 1,120
Inventories, net		 1,452 1,551
Prepaid Expenses		 143 88
Plant, Property, & Equipment, net		 0.00 0.00
Total Noncurrent Assets		 19,024 19,568
Goodwill		 8,917 9,020
Intangible Assets		 1,832 1,728
Other Noncurrent Operating Assets		 8,275 8,820
Total Liabilities & Shareholders' Equity		 23,805 24,249
Total Liabilities		 13,891 10,995
Total Current Liabilities		 2,550 2,857
Short-Term Debt		 134 333
Accounts Payable		 1,374 1,538
Other Current Liabilities		 1,042 986
Total Noncurrent Liabilities		 11,341 8,138
Long-Term Debt		 8,498 4,936
Noncurrent Deferred & Payable Income Tax Liabilities		 936 1,048
Other Noncurrent Operating Liabilities		 1,907 2,154
Commitments & Contingencies		 0.00 0.00
Total Equity & Noncontrolling Interests		 9,914 13,254
Total Preferred & Common Equity		 9,915 13,258
Total Common Equity		 9,915 13,258
Common Stock		 0.00 12,747
Retained Earnings		 0.00 902
Treasury Stock		 0.00 0.00
Accumulated Other Comprehensive Income / (Loss)		 -606 -391
Noncontrolling Interest		 -1.00 -4.00

Quarterly Balance Sheets for Amrize

This table presents Amrize's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2025 9/30/2025 3/31/2026
Total Assets		 23,782 24,035 24,269
Total Current Assets		 4,326 4,569 4,284
Cash & Equivalents		 601 826 1,099
Accounts Receivable		 1,892 2,046 1,358
Inventories, net		 1,641 1,511 1,567
Prepaid Expenses		 192 186 260
Plant, Property, & Equipment, net		 0.00 7,837 8,366
Total Noncurrent Assets		 19,456 11,629 11,619
Goodwill		 9,029 8,993 9,070
Intangible Assets		 1,797 1,762 1,703
Other Noncurrent Operating Assets		 8,630 874 846
Total Liabilities & Shareholders' Equity		 23,782 24,035 24,269
Total Liabilities		 11,349 11,137 11,181
Total Current Liabilities		 3,143 3,152 3,054
Short-Term Debt		 937 879 1,110
Accounts Payable		 1,355 1,322 1,021
Other Current Liabilities		 851 951 923
Total Noncurrent Liabilities		 8,206 7,985 8,127
Long-Term Debt		 5,261 4,932 4,936
Noncurrent Deferred & Payable Income Tax Liabilities		 928 946 1,104
Other Noncurrent Operating Liabilities		 2,017 2,107 2,087
Commitments & Contingencies		 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 12,433 12,898 13,088
Total Preferred & Common Equity		 12,434 12,901 13,094
Total Common Equity		 12,434 12,901 13,094
Common Stock		 12,736 12,740 12,753
Retained Earnings		 59 601 785
Treasury Stock		 0.00 0.00 0.00
Accumulated Other Comprehensive Income / (Loss)		 -361 -440 -444
Noncontrolling Interest		 -1.00 -3.00 -6.00

Annual Metrics And Ratios for Amrize

This table displays calculated financial ratios and metrics derived from Amrize's official financial filings.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - -
Revenue Growth		 0.00% 0.23% 0.95%
EBITDA Growth		 0.00% 12.06% -6.77%
EBIT Growth		 0.00% 15.55% -10.75%
NOPAT Growth		 0.00% 24.46% -12.24%
Net Income Growth		 0.00% 33.30% -7.15%
EPS Growth		 0.00% 32.95% -6.96%
Operating Cash Flow Growth		 0.00% 12.08% -3.24%
Free Cash Flow Firm Growth		 0.00% 0.00% 112.13%
Invested Capital Growth		 0.00% 0.00% -2.12%
Revenue Q/Q Growth		 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00%
Profitability Metrics		 - - -
Gross Margin		 23.71% 26.23% 25.68%
EBITDA Margin		 23.15% 25.88% 23.90%
Operating Margin		 16.17% 18.75% 16.13%
EBIT Margin		 15.86% 18.28% 16.17%
Profit (Net Income) Margin		 8.18% 10.88% 10.00%
Tax Burden Percent		 73.29% 78.19% 78.96%
Interest Burden Percent		 70.36% 76.07% 78.38%
Effective Tax Rate		 27.71% 22.60% 21.78%
Return on Invested Capital (ROIC)		 0.00% 20.03% 8.88%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 7.95% 2.94%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 5.65% 1.32%
Return on Equity (ROE)		 0.00% 25.68% 10.20%
Cash Return on Invested Capital (CROIC)		 0.00% -179.97% 11.03%
Operating Return on Assets (OROA)		 0.00% 8.99% 7.95%
Return on Assets (ROA)		 0.00% 5.35% 4.92%
Return on Common Equity (ROCE)		 0.00% 25.68% 10.21%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 1,365 1,699 1,491
NOPAT Margin		 11.69% 14.52% 12.62%
Net Nonoperating Expense Percent (NNEP)		 0.00% 12.09% 5.94%
Return On Investment Capital (ROIC_SIMPLE)		 - 9.16% 8.05%
Cost of Revenue to Revenue		 76.29% 73.77% 74.32%
SG&A Expenses to Revenue		 7.69% 8.07% 9.55%
R&D to Revenue		 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 7.54% 7.48% 9.55%
Earnings before Interest and Taxes (EBIT)		 1,852 2,140 1,910
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2,703 3,029 2,824
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.00 0.00 2.26
Price to Tangible Book Value (P/TBV)		 0.00 0.00 11.93
Price to Revenue (P/Rev)		 0.00 0.00 2.53
Price to Earnings (P/E)		 0.00 0.00 25.26
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 3.96%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 2.00
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 2.82
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 11.79
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 17.43
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 22.32
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 15.07
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 17.98
Leverage & Solvency		 - - -
Debt to Equity		 0.00 0.87 0.40
Long-Term Debt to Equity		 0.00 0.86 0.37
Financial Leverage		 0.00 0.71 0.45
Leverage Ratio		 0.00 2.40 2.07
Compound Leverage Factor		 0.00 1.83 1.63
Debt to Total Capital		 0.00% 46.54% 28.45%
Short-Term Debt to Total Capital		 0.00% 0.72% 1.80%
Long-Term Debt to Total Capital		 0.00% 45.82% 26.65%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% -0.01% -0.02%
Common Equity to Total Capital		 0.00% 53.46% 71.58%
Debt to EBITDA		 0.00 2.85 1.87
Net Debt to EBITDA		 0.00 2.33 1.19
Long-Term Debt to EBITDA		 0.00 2.81 1.75
Debt to NOPAT		 0.00 5.08 3.53
Net Debt to NOPAT		 0.00 4.15 2.24
Long-Term Debt to NOPAT		 0.00 5.00 3.31
Altman Z-Score		 0.00 0.00 2.52
Noncontrolling Interest Sharing Ratio		 0.00% -0.01% -0.02%
Liquidity Ratios		 - - -
Current Ratio		 0.00 1.87 1.64
Quick Ratio		 0.00 1.25 1.06
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 0.00 -15,262 1,851
Operating Cash Flow to CapEx		 350.43% 392.77% 287.87%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00
Efficiency Ratios		 - - -
Asset Turnover		 0.00 0.49 0.49
Accounts Receivable Turnover		 0.00 10.95 10.79
Inventory Turnover		 0.00 5.95 5.85
Fixed Asset Turnover		 0.00 0.00 0.00
Accounts Payable Turnover		 0.00 6.28 6.03
Days Sales Outstanding (DSO)		 0.00 33.34 33.81
Days Inventory Outstanding (DIO)		 0.00 61.38 62.41
Days Payable Outstanding (DPO)		 0.00 58.09 60.52
Cash Conversion Cycle (CCC)		 0.00 36.64 35.70
Capital & Investment Metrics		 - - -
Invested Capital		 0.00 16,961 16,601
Invested Capital Turnover		 0.00 1.38 0.70
Increase / (Decrease) in Invested Capital		 0.00 16,961 -360
Enterprise Value (EV)		 0.00 0.00 33,282
Market Capitalization		 0.00 0.00 29,939
Book Value per Share		 $0.00 $17.93 $23.97
Tangible Book Value per Share		 $0.00 ($1.51) $4.54
Total Capital		 0.00 18,546 18,523
Total Debt		 0.00 8,632 5,269
Total Long-Term Debt		 0.00 8,498 4,936
Net Debt		 0.00 7,047 3,347
Capital Expenditures (CapEx)		 581 581 767
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 780 235
Debt-free Net Working Capital (DFNWC)		 0.00 2,365 2,157
Net Working Capital (NWC)		 0.00 2,231 1,824
Net Nonoperating Expense (NNE)		 410 426 309
Net Nonoperating Obligations (NNO)		 0.00 7,047 3,347
Total Depreciation and Amortization (D&A)		 851 889 914
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 6.66% 1.99%
Debt-free Net Working Capital to Revenue		 0.00% 20.21% 18.26%
Net Working Capital to Revenue		 0.00% 19.06% 15.44%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $2.14
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 553.10M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $2.14
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 553.60M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 553.08M
Normalized Net Operating Profit after Tax (NOPAT)		 1,353 1,645 1,491
Normalized NOPAT Margin		 11.58% 14.06% 12.62%
Pre Tax Income Margin		 11.16% 13.91% 12.67%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Amrize

This table displays calculated financial ratios and metrics derived from Amrize's official financial filings.

Metric Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
DEI Shares Outstanding		 - - 0.00 - - 553,082,525.00
DEI Adjusted Shares Outstanding		 - - 0.00 - - 553,082,525.00
DEI Earnings Per Adjusted Shares Outstanding		 - - 0.00 - - -0.21
Growth Metrics		 - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% -0.71% 6.65% 4.66%
EBITDA Growth		 0.00% 0.00% 0.00% -11.14% -4.90% -20.69%
EBIT Growth		 0.00% 0.00% 0.00% -11.14% -6.60% -400.00%
NOPAT Growth		 0.00% 0.00% 0.00% -9.16% -7.49% -375.00%
Net Income Growth		 0.00% 0.00% 0.00% -9.51% -1.63% -35.63%
EPS Growth		 0.00% 0.00% 0.00% -9.30% -2.00% -31.25%
Operating Cash Flow Growth		 0.00% 0.00% 0.00% 0.00% 37.08% -4.67%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth		 0.00% 6.26% 0.00% 0.00% 14.13% 0.00%
EBITDA Q/Q Growth		 0.00% 40.72% 0.00% 0.00% 50.60% 0.00%
EBIT Q/Q Growth		 0.00% 10.48% 0.00% 0.00% 16.12% 0.00%
NOPAT Q/Q Growth		 0.00% 14.86% 0.00% 0.00% 16.97% 0.00%
Net Income Q/Q Growth		 0.00% 16.70% 0.00% 0.00% 26.87% 0.00%
EPS Q/Q Growth		 0.00% 16.28% 0.00% 0.00% 25.64% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% -149.57% 0.00% 0.00% -149.67%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 1.34% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% -0.82% 0.00%
Profitability Metrics		 - - - - - -
Gross Margin		 30.19% 30.24% 10.67% 30.00% 29.55% 9.69%
EBITDA Margin		 23.25% 30.79% 9.75% 20.81% 27.46% 7.39%
Operating Margin		 23.25% 24.49% -0.77% 20.78% 21.17% -3.49%
EBIT Margin		 23.25% 24.17% -0.72% 20.81% 21.17% -3.44%
Profit (Net Income) Margin		 14.59% 16.02% -4.18% 13.29% 14.78% -5.42%
Tax Burden Percent		 76.29% 78.52% 65.41% 77.96% 78.81% 81.38%
Interest Burden Percent		 82.23% 84.39% 886.67% 81.94% 88.56% 193.33%
Effective Tax Rate		 24.03% 22.05% 0.00% 22.22% 21.77% 0.00%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% -3.23%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% -5.85%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% -2.21%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 0.00% 0.00% -5.44%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 0.00% 0.00% -1.69%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 0.00% 0.00% -2.66%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 0.00% 0.00% -5.44%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 573 658 -11 520 609 -53
NOPAT Margin		 17.66% 19.09% -0.54% 16.16% 16.56% -2.44%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 3.30% 2.63% 2.62%
Return On Investment Capital (ROIC_SIMPLE)		 - - - 2.79% 3.25% -0.28%
Cost of Revenue to Revenue		 69.81% 69.76% 89.33% 70.00% 70.45% 90.31%
SG&A Expenses to Revenue		 7.03% 6.99% 11.48% 9.29% 8.49% 13.41%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 6.94% 5.75% 11.44% 9.22% 8.38% 13.18%
Earnings before Interest and Taxes (EBIT)		 754 833 -15 670 778 -75
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 754 1,061 203 670 1,009 161
Valuation Ratios		 - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 2.20 2.08 2.35
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 17.04 12.53 13.25
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 2.58
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 26.60
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 3.76%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 1.83 1.78 1.98
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 3.00
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 12.83
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 19.29
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 25.19
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 16.46
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.50 0.45 0.46
Long-Term Debt to Equity		 0.00 0.00 0.00 0.42 0.38 0.38
Financial Leverage		 0.00 0.00 0.00 0.45 0.39 0.38
Leverage Ratio		 0.00 0.00 0.00 1.91 1.86 1.85
Compound Leverage Factor		 0.00 0.00 0.00 1.57 1.65 3.59
Debt to Total Capital		 0.00% 0.00% 0.00% 33.27% 31.06% 31.60%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 5.03% 4.70% 5.80%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 28.24% 26.36% 25.80%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% -0.01% -0.02% -0.03%
Common Equity to Total Capital		 0.00% 0.00% 0.00% 66.74% 68.96% 68.43%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 2.17
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 1.78
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 1.77
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 4.27
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 3.49
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 3.48
Altman Z-Score		 0.00 0.00 0.00 0.00 0.00 2.24
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% -0.05%
Liquidity Ratios		 - - - - - -
Current Ratio		 0.00 0.00 0.00 1.38 1.45 1.40
Quick Ratio		 0.00 0.00 0.00 0.79 0.91 0.80
Cash Flow Metrics		 - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 0.00 -17,510 -17,274 -18,088
Operating Cash Flow to CapEx		 0.00% 308.42% -409.57% 0.00% 474.44% -335.58%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.00 0.00 0.49
Accounts Receivable Turnover		 0.00 0.00 0.00 0.00 0.00 8.77
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 5.67
Fixed Asset Turnover		 0.00 0.00 0.00 0.00 0.00 1.42
Accounts Payable Turnover		 0.00 0.00 0.00 0.00 0.00 8.71
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 0.00 0.00 41.61
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 64.34
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 0.00 0.00 41.92
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 0.00 0.00 64.03
Capital & Investment Metrics		 - - - - - -
Invested Capital		 0.00 0.00 0.00 18,030 17,883 18,035
Invested Capital Turnover		 0.00 0.00 0.00 0.00 0.00 1.32
Increase / (Decrease) in Invested Capital		 0.00 0.00 0.00 18,030 17,883 18,035
Enterprise Value (EV)		 0.00 0.00 0.00 33,002 31,863 35,692
Market Capitalization		 0.00 0.00 0.00 27,406 26,881 30,751
Book Value per Share		 $0.00 $0.00 $0.00 $22.48 $23.33 $23.67
Tangible Book Value per Share		 $0.00 $0.00 $0.00 $2.91 $3.88 $4.20
Total Capital		 0.00 0.00 0.00 18,631 18,709 19,134
Total Debt		 0.00 0.00 0.00 6,198 5,811 6,046
Total Long-Term Debt		 0.00 0.00 0.00 5,261 4,932 4,936
Net Debt		 0.00 0.00 0.00 5,597 4,985 4,947
Capital Expenditures (CapEx)		 0.00 202 209 0.00 180 267
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 0.00 0.00 1,519 1,470 1,241
Debt-free Net Working Capital (DFNWC)		 0.00 0.00 0.00 2,120 2,296 2,340
Net Working Capital (NWC)		 0.00 0.00 0.00 1,183 1,417 1,230
Net Nonoperating Expense (NNE)		 100 106 76 92 66 65
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 5,597 4,985 4,947
Total Depreciation and Amortization (D&A)		 0.00 228 218 0.00 231 236
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 10.42%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 19.64%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 10.33%
Earnings Adjustments		 - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $0.78 $0.99 ($0.21)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 553.10M 553.10M 553.20M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.78 $0.98 ($0.21)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 553.10M 553.90M 553.20M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 553.08M 553.08M 553.54M
Normalized Net Operating Profit after Tax (NOPAT)		 571 624 -12 519 605 -57
Normalized NOPAT Margin		 17.59% 18.12% -0.57% 16.11% 16.48% -2.60%
Pre Tax Income Margin		 19.12% 20.40% -6.39% 17.05% 18.75% -6.66%
Debt Service Ratios		 - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Here is a concise, quarter-by-quarter look at Amrize (AMRZ) using the latest four quarters of data (2024-2025). The focus is on cash flow, earnings, and balance-sheet trends that may matter to retail investors.

  • Operating cash flow remains strong and rising: Net cash from continuing operating activities was about $1.804 billion in Q4 2025, highlighting durable cash generation.
  • Strong free cash flow: With capital expenditures of $157 million in Q4 2025, free cash flow was roughly $1.65 billion.
  • Liquidity improving: Cash and cash equivalents grew from $601 million at the end of Q2 2025 to $826 million in Q3 2025, signaling better liquidity headroom.
  • Debt leverage easing: Long-term debt declined from $5.261 billion (Q2 2025) to $4.932 billion (Q3 2025), reducing leverage.
  • Revenue momentum: Q3 2025 revenue was $3.675 billion, up from Q2 2025’s $3.22 billion, indicating top-line growth.
  • Net income progression: Net income from continuing operations rose to $543 million in Q3 2025 vs. $428 million in Q2 2025, pointing to improving profitability.
  • Investing activity moderate: Net cash from continuing investing activities was negative but smaller in Q4 2025 at -$150 million versus -$202 million in Q3 2025, showing lower cash outflows for capex/acquisitions.
  • Financing activity drain: Net cash from financing activities was negative in Q4 2025 at approximately -$577 million (consistent with prior quarters), indicating ongoing use of cash for debt servicing or financing needs.
  • High liability base: Total liabilities stood around $11.14 billion in Q3 2025, signaling a substantial debt/load that could pose risks if rates or cash flow shift unfavorably.

Overall, Amrize shows robust cash generation and improving leverage with a healthier liquidity stance in 2025, though continued attention to financing activity and the large liabilities base is warranted.

05/19/26 03:35 PM ETAI Generated. May Contain Errors.

Amrize Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Amrize's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Amrize's net income appears to be on an upward trend, with a most recent value of $1.18 billion in 2025, rising from $955 million in 2023. The previous period was $1.27 billion in 2024. See where experts think Amrize is headed by visiting Amrize's forecast page.

Amrize's total operating income in 2025 was $1.91 billion, based on the following breakdown:
  • Total Gross Profit: $3.03 billion
  • Total Operating Expenses: $1.13 billion

Over the last 2 years, Amrize's total revenue changed from $11.68 billion in 2023 to $11.82 billion in 2025, a change of 1.2%.

Amrize's total liabilities were at $11.00 billion at the end of 2025, a 20.8% decrease from 2024, and a 20.8% decrease since 2024.

In the past 1 years, Amrize's cash and equivalents has ranged from $1.59 billion in 2024 to $1.92 billion in 2025, and is currently $1.92 billion as of their latest financial filing in 2025.

Over the last 2 years, Amrize's book value per share changed from 0.00 in 2023 to 23.97 in 2025, a change of 2,397.1%.


Related Companies

Financial statements for NYSE:AMRZ last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel